Personal information

Verified email addresses

Verified email domains

Austria

Activities

Employment (1)

Medical University of Innsbruck: Innsbruck, AT

Resident Doctor (Department of Obstetrics and Gynecology)
Employment
Source: Self-asserted source
Irina Tsibulak

Works (20)

Global survey on training and practice in sentinel lymph node mapping for endometrial and cervical cancer among early-career gynecologic oncologists

International Journal of Gynecological Cancer
2025-02 | Journal article
Contributors: Irina Tsibulak; Anna Collins; Heng-Cheng Hsu; Enrique Chacon; Nicolò Bizzarri; Alex Mutombo Baleka; Zoia Razumova; Charalampos Theofanakis; Joanna Kacperczyk-Bartnik; Alexandra Natalia Strojna et al.
Source: check_circle
Crossref

Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-Mitte

International Journal of Gynecological Cancer
2025-02 | Journal article
Contributors: Irina Tsibulak; Rozita Hashemi; Julia Welz; Malak Moubarak; Kristina Zdanyte; Alexander Traut; Christian Müller; Sebastian Heikaus; Sarah Förster; Christoph Schmitt et al.
Source: check_circle
Crossref

Global practice patterns of sentinel lymph node biopsy in endometrial cancer: a survey from the European Network of Young Gynecologic Oncologists (ENYGO)

International Journal of Gynecological Cancer
2024-12 | Journal article
Contributors: Enrique Chacon; Houssein El Hajj; Heng-Cheng Hsu; Nicolò Bizzarri; Irina Tsibulak; Anna Collins; Andrej Cokan; Tibor A. Zwimpfer; Aleksandra N. Strojna; Martina Aida Angeles et al.
Source: check_circle
Crossref

Tumor biology and impact on timing of surgery in advanced epithelial ovarian cancer

International Journal of Gynecological Cancer
2023-10 | Journal article
Contributors: Irina Tsibulak; Christina Fotopoulou
Source: check_circle
Crossref

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Wiener klinische Wochenschrift
2022-10 | Journal article
Contributors: Irina Tsibulak; Stephan Polterauer; Alexander Reinthaller; Christian Schauer; Jürg Berger; Christian Marth
Source: check_circle
Crossref

The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective

Archives of Gynecology and Obstetrics
2022-04 | Journal article
Contributors: Katharina Knoll; Elisabeth Reiser; Katharina Leitner; Johanna Kögl; Christoph Ebner; Christian Marth; Irina Tsibulak
Source: check_circle
Crossref

The Impact of COVID-19 Pandemic on Gynecological and Breast Cancer Detection Rate: A Tertiary Center Perspective.

2021-07-20 | Other
Contributors: Katharina Knoll; Elisabeth Reiser; Katharina Leitner; Johanna Kögl; Christoph Ebner; Christian Marth; Irina Tsibulak
Source: check_circle
Crossref

Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort

Acta oncologica (Stockholm, Sweden)
2020 | Journal article
Part of ISSN: 0284-186X
Source: Self-asserted source
Irina Tsibulak
grade
Preferred source (of 2)‎

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer

Scientific reports
2020 | Journal article
Part of ISSN: 2045-2322
Source: Self-asserted source
Irina Tsibulak

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective

International Journal of Gynecologic Cancer
2020-10-08 | Journal article
Part of ISSN: 1048-891X
Part of ISSN: 1525-1438
Source: Self-asserted source
Irina Tsibulak
grade
Preferred source (of 2)‎

Delaying surgery for patients with a previous SARS-CoV-2 infection

British Journal of Surgery
2020-09-25 | Journal article
Part of ISSN: 0007-1323
Source: Self-asserted source
Irina Tsibulak

The miR-34 family and its clinical significance in ovarian cancer.

Journal of Cancer
2020-01-13 | Journal article
Source: Self-asserted source
Irina Tsibulak

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.

Gynecologic oncology
2019-09-10 | Journal article
Source: Self-asserted source
Irina Tsibulak

Hopes and failures in front-line ovarian cancer therapy.

Critical reviews in oncology/hematology
2019-08-14 | Journal article
Source: Self-asserted source
Irina Tsibulak

Clinical Impact of RANK Signalling in Ovarian Cancer.

Cancers
2019-06-08 | Journal article
Source: Self-asserted source
Irina Tsibulak
grade
Preferred source (of 2)‎

Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.

Cancer science
2019-02-16 | Journal article
Source: Self-asserted source
Irina Tsibulak

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2019-02-01 | Journal article
Source: Self-asserted source
Irina Tsibulak

Immunotherapy in ovarian cancer: fake news or the real deal?

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
2019-01-01 | Journal article
Source: Self-asserted source
Irina Tsibulak

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.

British journal of cancer
2018-08-15 | Journal article
Source: Self-asserted source
Irina Tsibulak

Dynamics of anti-Müllerian hormone during controlled ovarian stimulation.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
2013-12-06 | Journal article
Source: Self-asserted source
Irina Tsibulak

Peer review (6 reviews for 3 publications/grants)

Review activity for Cancers. (1)
Review activity for Magazine of European medical oncology. (4)
Review activity for Wiener klinische Wochenschrift. (1)